Notice Title

Consent to the Distribution of New Medicines

Publication Date
6 Mar 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go1199
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Colecalciferol
Active Ingredient: Colecalciferol 1.25mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Teva Gyogyszergyar Zrt, Debrecen, Hungary
   
Product: Fempro
Active Ingredient: Progesterone 200mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Laboratorios Leon Farma S.A., Leon, Spain
   
Product: Progesterone-Teva
Active Ingredient: Progesterone 100mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Laboratorios Leon Farma S.A., Leon, Spain
   
Product: Progesterone-Teva
Active Ingredient: Progesterone 200mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Laboratorios Leon Farma S.A., Leon, Spain


Dated this 4th day of March 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).